NO912497L - DOSAGE FORM FOR ADMINISTRATION OF CALCIUM ANTAGONIST. - Google Patents

DOSAGE FORM FOR ADMINISTRATION OF CALCIUM ANTAGONIST.

Info

Publication number
NO912497L
NO912497L NO91912497A NO912497A NO912497L NO 912497 L NO912497 L NO 912497L NO 91912497 A NO91912497 A NO 91912497A NO 912497 A NO912497 A NO 912497A NO 912497 L NO912497 L NO 912497L
Authority
NO
Norway
Prior art keywords
administration
dosage form
calcium antagonist
antagonist
calcium
Prior art date
Application number
NO91912497A
Other languages
Norwegian (no)
Other versions
NO912497D0 (en
Inventor
Joseph C Deters
David R Swanson
Stephen C De Rosa
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US1989/005670 external-priority patent/WO1990008536A1/en
Application filed by Alza Corp filed Critical Alza Corp
Publication of NO912497D0 publication Critical patent/NO912497D0/en
Publication of NO912497L publication Critical patent/NO912497L/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Doseringsform (10) omfattende en komponent valgt blant nikardipin og farmasøytisk akseptable salter derav for admi- nistrering til en pasient som trenger kardiovaskulærterapi.Dosage form (10) comprising a component selected from nicardipine and pharmaceutically acceptable salts thereof for administration to a patient in need of cardiovascular therapy.

NO91912497A 1989-01-30 1991-06-26 DOSAGE FORM FOR ADMINISTRATION OF CALCIUM ANTAGONIST. NO912497L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30370689A 1989-01-30 1989-01-30
PCT/US1989/005670 WO1990008536A1 (en) 1989-01-30 1989-12-18 Dosage form for administering calcium antagonist

Publications (2)

Publication Number Publication Date
NO912497D0 NO912497D0 (en) 1991-06-26
NO912497L true NO912497L (en) 1991-07-15

Family

ID=26780178

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91912497A NO912497L (en) 1989-01-30 1991-06-26 DOSAGE FORM FOR ADMINISTRATION OF CALCIUM ANTAGONIST.

Country Status (2)

Country Link
DE (1) DE68905343T2 (en)
NO (1) NO912497L (en)

Also Published As

Publication number Publication date
DE68905343T2 (en) 1993-06-17
DE68905343D1 (en) 1993-04-15
NO912497D0 (en) 1991-06-26

Similar Documents

Publication Publication Date Title
NZ336055A (en) An oral sustained release formulation of opioids
ES2099275T3 (en) COMPRESSED MULTIPARTICLES OF QUICK DISSOLUTION.
NO306377B1 (en) Dosage form for delivery of a drug
ATE211387T1 (en) ORAL 1ALPHA-HYDROXYPREVITAMIN D
NO944565D0 (en) Controlled release preparation containing a morphine salt
DE69636104D1 (en) Oral pharmaceutical composition with sustained-release of proton pump inhibitors
ATE215816T1 (en) SOLID ORAL MEDICINAL FORM
NO920740L (en) DOSAGE FORM FOR ORAL ADMINISTRATION OF HYPOGLYCHEMIC GLIPIZID
IS3959A (en) Method of preparation of a composition comprising a medicament which is a bronchodilator and anti-inflammatory drug for the treatment and use of respiratory disorders
IS4146A (en) A pharmaceutical preparation for oral administration of proton pump blockers
ES2026304A6 (en) Dosage form for administering calcium antagonist.
NO923859L (en) DRUG
EE04606B1 (en) Use of H +, K + -ATPase Inhibitor in the manufacture of a medicament for oral administration
NZ229518A (en) Pharmaceutical dosage form for the medication of fish: method of administration and (prophylactic) treatment
MX9706957A (en) Composition containing amlodipine, or a salt or felodipine and anace inhibitor.
LV10268A (en) Therapeutically active benzimidazole and its retention
NO962752L (en) Use of 2,3-diaryl-1-benzopyran derivatives in the manufacture of a medicament for the treatment and prevention of bone loss and osteoporosis
CS734389A3 (en) 4-fluoro-2-//(4-methoxy-2-pyridyl)methyl/sulfinyl/ -1h - benzimidazole, process for its production and a pharmaceutical comprising said compound as an active component
NO912497L (en) DOSAGE FORM FOR ADMINISTRATION OF CALCIUM ANTAGONIST.
GB9917290D0 (en) Pharmaceutical composition
SE8304818D0 (en) A MEDICINE HAVING ANTI-ULCER, SPASMOLYTIC AND LOCALLY ANESTHETIC EFFECT
MY103532A (en) A liquid dosage form for oral administration of a pharmaceutically active substance
IT1317079B1 (en) USE OF ISOVALERIL L-CARNITINE FOR THE PREPARATION OF A MEDICATION FOR THE PREVENTION AND TREATMENT OF OSTEOPOROSIS.